179 related articles for article (PubMed ID: 31734586)
1. Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018.
Reale ML; De Luca E; Lombardi P; Marandino L; Zichi C; Pignataro D; Ghisoni E; Di Stefano RF; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Bironzo P; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Lung Cancer; 2020 Jan; 139():47-54. PubMed ID: 31734586
[TBL] [Abstract][Full Text] [Related]
2. Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.
Lombardi P; Marandino L; De Luca E; Zichi C; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Leone F; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Crit Rev Oncol Hematol; 2020 Feb; 146():102877. PubMed ID: 31981880
[TBL] [Abstract][Full Text] [Related]
3. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M
Ann Oncol; 2018 Dec; 29(12):2288-2295. PubMed ID: 30304498
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018.
Marandino L; De Luca E; Zichi C; Lombardi P; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Buttigliero C; Tucci M; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Clin Genitourin Cancer; 2019 Oct; 17(5):332-347.e2. PubMed ID: 31416754
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC.
Salomone F; Di Costanzo F; Pecoraro G; Viscardi G; Viggiano A; Napolitano F; Santaniello A; Formisano L; Bianco R; Servetto A
Lung Cancer; 2022 Dec; 174():36-44. PubMed ID: 36302311
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatments.
Notarnicola S; Zumstein L; Paparo J; Marandino L; Perrone F; Di Maio M
Eur J Cancer; 2023 Dec; 195():113374. PubMed ID: 38557561
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of Health-Related Quality of Life Reporting in Ovarian Cancer Phase III Clinical Trials: Room to Improve.
Wilson MK; Friedlander ML; Joly F; Oza AM
Oncologist; 2018 Feb; 23(2):203-213. PubMed ID: 29118265
[TBL] [Abstract][Full Text] [Related]
8. Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review.
Servetto A; Salomone F; Di Costanzo F; Iuliano R; Marandino L; Napolitano F; Santaniello A; De Placido P; De Placido S; Di Maio M; Formisano L; Bianco R
Crit Rev Oncol Hematol; 2022 Apr; 172():103649. PubMed ID: 35259486
[TBL] [Abstract][Full Text] [Related]
9. Toxicity and quality of life in published clinical trials for advanced lung cancer.
Zwitter M
Support Care Cancer; 2018 Oct; 26(10):3453-3459. PubMed ID: 29681014
[TBL] [Abstract][Full Text] [Related]
10. Locally advanced non-small cell lung cancer: do we know the questions? A survey of randomized trials from 1966-1993.
Brundage MD; Mackillop WJ
J Clin Epidemiol; 1996 Feb; 49(2):183-92. PubMed ID: 8606319
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
[TBL] [Abstract][Full Text] [Related]
12. Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.
Zichi C; Paratore C; Gargiulo P; Mariniello A; Reale ML; Audisio M; Bungaro M; Caglio A; Gamba T; Perrone F; Di Maio M
Eur J Cancer; 2021 May; 149():49-60. PubMed ID: 33823362
[TBL] [Abstract][Full Text] [Related]
13. Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer.
Hollen PJ; Gralla RJ; Rittenberg CN
Support Care Cancer; 2004 Nov; 12(11):767-73. PubMed ID: 15206013
[TBL] [Abstract][Full Text] [Related]
14. Trends in endpoint selection and result interpretation in advanced non-small cell lung cancer clinical trials published between 2000 and 2012: A retrospective cohort study.
Fernández-López C; Calleja-Hernández MÁ; Balbino JE; Cabeza-Barrera J; Expósito-Hernández J
Thorac Cancer; 2019 Apr; 10(4):904-908. PubMed ID: 30868737
[TBL] [Abstract][Full Text] [Related]
15. Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials.
Saad ED; Adamowicz K; Katz A; Jassem J
Cancer Treat Rev; 2012 Oct; 38(6):807-14. PubMed ID: 22445316
[TBL] [Abstract][Full Text] [Related]
16. Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.
Adamowicz K
Qual Life Res; 2017 Apr; 26(4):813-822. PubMed ID: 27738867
[TBL] [Abstract][Full Text] [Related]
17. Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
Gralla RJ; Griesinger F
J Thorac Oncol; 2007 Jun; 2 Suppl 2():S51-8. PubMed ID: 17589300
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review.
Rizzo A; Mollica V; Dall'Olio FG; Ricci AD; Maggio I; Marchetti A; Rosellini M; Santoni M; Ardizzoni A; Massari F
Future Oncol; 2021 Jul; 17(20):2671-2681. PubMed ID: 33880963
[TBL] [Abstract][Full Text] [Related]
19. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
Fiteni F; Anota A; Westeel V; Bonnetain F
BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
[TBL] [Abstract][Full Text] [Related]
20. Assessment of quality of life in phase III trials of radiotherapy in localized or locally advanced head and neck cancer over the past 17 years.
Marta GN; Saad ED
Ann Palliat Med; 2017 Jan; 6(1):73-80. PubMed ID: 28209070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
